Arcellx's innovative cell therapy platform shows promising potential in treating multiple myeloma, a significant unmet ...
Data collected by Pune Municipal Corporation (PMC) health department has revealed that the Guillain-Barré Syndrome (GBS) ...
Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...
Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.
There is a significant decline in GBS cases and the situation is under control. However, few sporadic cases are still being ...
Crimes deserve punishment. But taking away a human's liberty is a fearsome power, and we should not make it more intolerable ...
Stocks surged on Friday, with the S&P 500 soaring 2.13% as investors welcomed a break from tariff-driven turmoil. The market ...
I foolishly was in a crowded indoor location and got COVID (for the third time). I thought about getting Paxlovid. But I ...
Almost without fail, a person will enter the examination room, make no introduction, and launch into a series of questions or ...
Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due ...
The story of Hardel Sherrell’s treatment behind bars has been at the center of a years-long KARE 11 Investigation into ...
Nashik has reported its first case of Guillain-Barre Syndrome in a 60-year-old man. The condition, which causes the immune system to attack peripheral nerves, has been reported in 250 cases in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results